James is among Canada's most successful biotechnology entrepreneurs and founding CEO of QLT Inc. and Inex Pharmaceuticals. As portfolio manager for Trian Equities, he has been instrumental in investing and providing guidance to a variety of technology companies. Currently, he is the Chairman of Allon Therapeutics and Managing Partner of NDI Capital.
Reg was the CEO and President of Vortek Industries and was responsible for its successful sale to Mattson Technology. He has a broad background in product development, sales, marketing, and business leadership and has raised in excess of $30-million in funding from Canada, the US and Europe. He is a professional engineer, starting his career in research, then progressing through to executive level management.
Denis was the Chairman and founding CEO of QuestAir Technologies, an advanced gas separation company focused on oxygen and hydrogen production. Prior to joining QuestAir, he led the Science Council of British Columbia and was the founding director of Fuel Cells Canada. Early in his career, Denis spent twelve years at MacDonald Dettwiler in executive positions. Denis is a director of General Fusion and Carbon Engineering. He holds a Ph.D. in electrical engineering from the University of British Columbia.